This inventor holds 2 USPTO granted patents. Top assignee: Columbia University. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Steven Siegelbaum: Innovator in Ion Channel Research
Introduction
Steven Siegelbaum is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of neuroscience and cardiology through his innovative research and patents. With a total of 2 patents, Siegelbaum's work focuses on brain and heart cyclic nucleotide gated ion channels.
Latest Patents
Siegelbaum's latest patents include groundbreaking inventions related to cyclic nucleotide gated ion channels. The first patent, titled "Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof," provides an isolated nucleic acid encoding a BCNG protein. This invention outlines methods for identifying nucleic acids that encode BCNG proteins and testing compounds that affect their expression. Additionally, it offers methods for identifying compounds that can modulate BCNG protein activity and treat related conditions.
The second patent, "Brain cyclic nucleotide gated ion channel and uses thereof," presents an isolated nucleic acid molecule encoding a BCNG protein. This patent also describes methods for evaluating the ability of compounds to interact with BCNG-related proteins and treat neurological, cardiac, or renal conditions. Furthermore, it includes the provision of an antibody that specifically reacts with BCNG protein.
Career Highlights
Steven Siegelbaum is affiliated with Columbia University, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential applications in treating various medical conditions related to ion channel dysfunction.
Collaborations
Siegelbaum has collaborated with notable colleagues, including Eric R. Kandel and Bina Santoro. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
Steven Siegelbaum's innovative work in the field of ion channels has led to significant advancements in understanding and treating neurological and cardiac conditions. His contributions continue to influence the scientific community and pave the way for future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile